POLOCAINE-MPF

Generic: MEPIVACAINE HYDROCHLORIDE

Fresenius Kabi USAManufacturer
EPIDURAL, INFILTRATIONRoute
MEPIVACAINE HYDROCHLORIDEActive Substance
1986-12-01Original Approval

POLOCAINE-MPF is FDA application ANDA089408, sponsored by FRESENIUS KABI USA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Class II2025-10-31
3% Polocaine DENTAL, Mepivacaine Hydrochloride 3% (30mg/mL) (Mepivacaine HCI Injection, USP), packaged in a carton conta

Defective container: cracked/broken cartridges

Top Reported Reactions

1
DRUG INEFFECTIVE
42 reports
2
OFF LABEL USE
30 reports
3
HYPOTENSION
26 reports
4
DYSPNOEA
21 reports
5
NAUSEA
19 reports
6
DIZZINESS
18 reports
7
MONOPLEGIA
17 reports
8
PRURITUS
16 reports
9
SEIZURE
14 reports
10
SYNCOPE
13 reports